SLC5A5 and thyroid cancer: To better understand how CQ influences NIS function, we characterised NIS expression at the PM via cell surface biotinylation assays (CSBA), which demonstrated elevated levels of cell-surface NIS in CQ-treated thyroid cancer cells (Fig. 4D).